A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.
about
Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey.Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?Water prescription in autosomal dominant polycystic kidney disease: a pilot study.Autosomal dominant polycystic kidney disease in children.Caffeine intake by patients with autosomal dominant polycystic kidney disease.The chronic kidney disease Water Intake Trial (WIT): results from the pilot randomised controlled trialMultidrug therapy for polycystic kidney disease: a review and perspective.New treatments for autosomal dominant polycystic kidney diseaseEffects of dietary interventions on incidence and progression of CKD.New options in the treatment of autosomal dominant polycystic kidney disease.The Chronic Kidney Disease Water Intake Trial: Protocol of a Randomized Controlled TrialA systematic review to determine the most effective interventions to increase water intake.Clinical Trials and a View Toward the Future of ADPKD.The vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).Nutritional therapy in autosomal dominant polycystic kidney disease.A case of nephrogenic syndrome of inappropriate antidiuresis caused by carbamazepine.Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.New treatment paradigms for ADPKD: moving towards precision medicine.Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial.Cystic Kidney Diseases From the Adult Nephrologist's Point of View.Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects.
P2860
Q33783023-C32EB5E0-C7D3-468B-ABE0-16D315C1A874Q34094366-F3D28A36-6055-4B84-8847-89E24644AB5BQ34497230-86775B71-68ED-46E3-B457-5331834D38D2Q35596375-4E786AFF-96BC-4D48-848C-411C82E2AA97Q37371261-1DBFA6E6-E5B3-4793-B454-78B703FFF76CQ37448445-DDBEADB4-FEC4-487E-9CFD-8DF20CD49904Q38083427-D71AA42C-C646-409E-9965-E8F76EED52CBQ38099698-8504BAAA-647C-4586-B58E-FC8C1088D7DBQ38261585-2520927E-CEA1-4DBE-AC03-10B909D026D2Q38356125-87532D54-3E1C-49A9-85BC-D8C651969E25Q38371440-1AD3AA46-8200-4A37-A0DD-15E3B7AD46FCQ38645406-DED5316D-AF89-4627-AAD6-64C415B5773FQ38812543-57025125-7282-4CD2-9AFB-C880CCA6A5D2Q41998074-A4DBA296-AFE3-45E0-ADA9-8E5F01A0AA98Q47705916-38437E8B-81EE-497D-B5BB-C4A237C118B7Q47712039-B559ADB3-4990-46D2-962A-E75E1A5D35DAQ47739292-5FB6AC3D-12E8-4D51-B38A-4FC894D17212Q48701839-01A267EC-306A-494E-8925-3916729B4640Q49494721-BBD43508-0D78-4D5F-B663-3F49EF45D051Q50350995-2F6C44D8-3DA0-40AB-80E9-C855C12FDF26Q52330435-557AB2D2-4756-42E0-9B16-9B8E0959B895Q52668626-B97BAEC7-E2D8-4763-9261-D5F3A65F90FAQ53603650-A024140D-CD29-48E2-8296-CDFB09F69181Q53823696-DFB70FDB-2116-4284-87BD-E5357F5A7BF2Q54540098-0F7EAB95-0A96-4E00-B21B-DB1D04BE4D0D
P2860
A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A pilot clinical study to eval ...... ant polycystic kidney disease.
@ast
A pilot clinical study to eval ...... ant polycystic kidney disease.
@en
type
label
A pilot clinical study to eval ...... ant polycystic kidney disease.
@ast
A pilot clinical study to eval ...... ant polycystic kidney disease.
@en
prefLabel
A pilot clinical study to eval ...... ant polycystic kidney disease.
@ast
A pilot clinical study to eval ...... ant polycystic kidney disease.
@en
P2093
P2860
P356
P1476
A pilot clinical study to eval ...... ant polycystic kidney disease.
@en
P2093
Edward Y Skolnik
Irina Barash
Manish P Ponda
P2860
P304
P356
10.2215/CJN.04180609
P577
2010-02-18T00:00:00Z